Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Background: Metformin use reportedly reduces cancer risk and improves survival in lung cancer patients. This study aimed to investigate the effect of metformin use in patients with diabetes mellitus (DM) and lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Ming-Szu, Chuang, Min-Chun, Chen, Yi-Chuan, Lee, Chuan-Pin, Yang, Tsung-Ming, Chen, Pau-Chung, Tsai, Ying-Huang, Yang, Yao-Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696848/
https://www.ncbi.nlm.nih.gov/pubmed/31409137
http://dx.doi.org/10.1177/1534735419869491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696848/
https://www.ncbi.nlm.nih.gov/pubmed/31409137
http://dx.doi.org/10.1177/1534735419869491

Ejemplares similares